| P2093 | author name string | J T Brouwer | |
| | S W Schalm | |
| | H Van Vlierberghe | |
| | G Leroux-Roels | |
| | A Elewaut | |
| | F C Bekkering | |
| P2860 | cites work | Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. | Q36865888 |
| | International collaborative study on the second EUROHEP HCV-RNA reference panel | Q42978378 |
| | Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients | Q42989126 |
| | Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C | Q43038103 |
| | Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin | Q43040784 |
| | Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa | Q45761962 |
| | Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration | Q71650797 |
| | National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C | Q73717356 |
| P433 | issue | 6 | |
| P921 | main subject | hepatitis C | Q154869 |
| | Hepatitis C virus | Q708693 |
| P304 | page(s) | 960-964 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy | |
| P478 | volume | 28 | |